logo

ITI Pharma and Healthcare Fund - Regular Plan - Growth Option

Category: Equity: Sectoral-Pharma and Healthcare Launch Date: 08-11-2021
AUM:

₹ 156.65 Cr

Expense Ratio

2.34%

Benchmark

NIFTY Healthcare TRI

ISIN

INF00XX01BL5

Minimum Investment

5000.0

Minimum Topup

1000.0

Minimum SIP Amount

500

Fund Manager

Dhimant Shah, Rohan Korde, Rajesh Bhatia

Fund Performance 1Y (%) 3Y (%) 5Y (%)
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 42.92 - -
NIFTY Healthcare TRI 50.07 13.77 22.74
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%

Overview

NAV
14.116
Last change
0.13 (0.9302%)
Fund Size (AUM)
₹ 156.65 Cr
Performance
14.18% (Inception)

Asset Allocation

Equity

Debt

Others

Nav Movement

Investment Objective

The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.

Fund Manager
Dhimant Shah, Rohan Korde, Rajesh Bhatia
Riskometer
Very High

Top 10 Holdings

Company Holdings (%)
Sun Pharmaceutical Industries Ltd. 15.87
Dr. Reddy's Laboratories Ltd. 7.24
Lupin Ltd. 6.19
Max Healthcare Institute Ltd. 5.69
Apollo Hospitals Enterprise Ltd. 4.82
Divi's Laboratories Ltd. 4.6
Suven Pharmaceuticals Ltd. 4.43
Zydus Lifesciences Ltd. 3.93
Laurus Labs Ltd. 2.82
Syngene International Ltd. 2.58

Sector Allocation

Sector Holdings (%)
Healthcare 96.77
Chemicals 2.75
Others 0.48